These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 23867235)

  • 1. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis.
    Schrag M; Mueller C; Zabel M; Crofton A; Kirsch WM; Ghribi O; Squitti R; Perry G
    Neurobiol Dis; 2013 Nov; 59():100-10. PubMed ID: 23867235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
    Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
    J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer's disease brain: A meta-analysis in human pathological specimens.
    Zabel M; Nackenoff A; Kirsch WM; Harrison FE; Perry G; Schrag M
    Free Radic Biol Med; 2018 Feb; 115():351-360. PubMed ID: 29253591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of thiol-disulfıte balance, ischemıa albumın modıfıcation and seruloplazmine as a new oxidatıve stress in mild cognitive impairment and early stage alzheimer's disease patients.
    Gündüztepe Y; Bukan N; Zorlu E; Karaman Y; Andaç Topkan T; Gurbuz N; Neşelioğlu S; Erel Ö
    J Clin Neurosci; 2020 May; 75():188-194. PubMed ID: 32223973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.
    Padurariu M; Ciobica A; Hritcu L; Stoica B; Bild W; Stefanescu C
    Neurosci Lett; 2010 Jan; 469(1):6-10. PubMed ID: 19914330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of biomarkers of oxidative stress and antioxidant in Alzheimer's disease: a systematic review.
    Chang YT; Chang WN; Tsai NW; Huang CC; Kung CT; Su YJ; Lin WC; Cheng BC; Su CM; Chiang YF; Lu CH
    Biomed Res Int; 2014; 2014():182303. PubMed ID: 24949424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress in Alzheimer's disease and mild cognitive impairment with high sensitivity and specificity.
    López N; Tormo C; De Blas I; Llinares I; Alom J
    J Alzheimers Dis; 2013; 33(3):823-9. PubMed ID: 23076075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper subtype of Alzheimer's disease (AD): meta-analyses, genetic studies and predictive value of non-ceruloplasmim copper in mild cognitive impairment conversion to full AD.
    Squitti R
    J Trace Elem Med Biol; 2014 Oct; 28(4):482-5. PubMed ID: 25066791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary pattern and antioxidants in plasma and erythrocyte in patients with mild cognitive impairment from China.
    Yuan L; Liu J; Ma W; Dong L; Wang W; Che R; Xiao R
    Nutrition; 2016 Feb; 32(2):193-8. PubMed ID: 26690564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts.
    Muenchhoff J; Poljak A; Song F; Raftery M; Brodaty H; Duncan M; McEvoy M; Attia J; Schofield PW; Sachdev PS
    J Alzheimers Dis; 2015; 43(4):1355-73. PubMed ID: 25159666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment.
    Mangialasche F; Baglioni M; Cecchetti R; Kivipelto M; Ruggiero C; Piobbico D; Kussmaul L; Monastero R; Brancorsini S; Mecocci P
    J Alzheimers Dis; 2015; 44(2):649-60. PubMed ID: 25322927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers.
    Gubandru M; Margina D; Tsitsimpikou C; Goutzourelas N; Tsarouhas K; Ilie M; Tsatsakis AM; Kouretas D
    Food Chem Toxicol; 2013 Nov; 61():209-14. PubMed ID: 23871825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular bases of the treatment of Alzheimer's disease with antioxidants: prevention of oxidative stress.
    Viña J; Lloret A; Ortí R; Alonso D
    Mol Aspects Med; 2004; 25(1-2):117-23. PubMed ID: 15051321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary Data on the Interaction between Some Biometals and Oxidative Stress Status in Mild Cognitive Impairment and Alzheimer's Disease Patients.
    Balmuș IM; Strungaru SA; Ciobica A; Nicoara MN; Dobrin R; Plavan G; Ștefănescu C
    Oxid Med Cell Longev; 2017; 2017():7156928. PubMed ID: 28811866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia.
    Cervellati C; Romani A; Seripa D; Cremonini E; Bosi C; Magon S; Passaro A; Bergamini CM; Pilotto A; Zuliani G
    J Neurol Sci; 2014 Feb; 337(1-2):156-61. PubMed ID: 24321755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer's disease or vascular dementia.
    Cervellati C; Romani A; Bergamini CM; Bosi C; Sanz JM; Passaro A; Zuliani G
    Clin Chem Lab Med; 2015 Jun; 53(7):1049-56. PubMed ID: 25490030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Extracellular and Intracellular Blood Compartments Highlights Redox Alterations in Alzheimer's and Mild Cognitive Impairment Patients.
    Arce-Varas N; Abate G; Prandelli C; Martínez C; Cuetos F; Menéndez M; Marziano M; Cabrera-García D; Fernández-Sánchez MT; Novelli A; Memo M; Uberti D
    Curr Alzheimer Res; 2017; 14(1):112-122. PubMed ID: 27748187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients.
    Hatanaka H; Hanyu H; Fukasawa R; Hirao K; Shimizu S; Kanetaka H; Iwamoto T
    Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():53-8. PubMed ID: 26671158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an antioxidant beverage on biomarkers of oxidative stress in Alzheimer's patients.
    Rubio-Perez JM; Albaladejo MD; Zafrilla P; Vidal-Guevara ML; Morillas-Ruiz JM
    Eur J Nutr; 2016 Sep; 55(6):2105-16. PubMed ID: 26298312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.